TP53-positive clones are responsible for drug-tolerant persister and recurrence of HER2-positive breast cancer. Watanabe H, Nakagomi H, Hirotsu Y, Amemiya K, et al. Breast Cancer Res Treat 2022 Sep 10. pii: 10.1007/s10549-022-06731.

Read + Share

Amedeo Smart

Independent Medical Education

Watanabe H, Nakagomi H, Hirotsu Y, Amemiya K, et al. TP53-positive clones are responsible for drug-tolerant persister and recurrence of HER2-positive breast cancer. Breast Cancer Res Treat 2022 Sep 10. pii: 10.1007/s10549-022-06731.
PMID: 36087189